GWSG
GSK icon

GPS Wealth Strategies Group’s GSK GSK Stock Holding History

GPS Wealth Strategies Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$32.4K Sell
660
-1,165
-64% -$54.3K 0.03% 261
2025
Q3 		$78.8K Hold
1,825
– – 0.01% 559
2025
Q2 		$70.1K Sell
1,825
-619
-25% -$23.7K 0.01% 567
2025
Q1 		$94.7K Buy
2,444
+113
+5% +$4.14K 0.01% 466
2024
Q4 		$78.8K Sell
2,331
-140
-6% -$5.04K 0.01% 484
2024
Q3 		$101K Buy
2,471
+46
+2% +$1.88K 0.01% 429
2024
Q2 		$93.4K Sell
2,425
-300
-11% -$12.6K 0.01% 406
2024
Q1 		$117K Sell
2,725
-160
-6% -$6.6K 0.02% 348
2023
Q4 		$107K Sell
2,885
-525
-15% -$18.8K 0.02% 350
2023
Q3 		$124K Buy
3,410
+686
+25% +$24.3K 0.02% 317
2023
Q2 		$97.1K Buy
2,724
+102
+4% +$3.66K 0.02% 376
2023
Q1 		$93.3K Buy
+2,622
New +$91.7K 0.02% 361
2022
Q4 		– Sell
-2,127
Closed -$63K – 522
2022
Q3 		$63K Buy
2,127
+4
+0.2% +$152 0.02% 393
2022
Q2 		$116K Sell
2,123
-62
-3% -$3.42K 0.03% 286
2022
Q1 		$119K Sell
2,185
-74
-3% -$4.02K 0.03% 276
2021
Q4 		$125K Buy
2,259
+11
+0.5% +$572 0.03% 267
2021
Q3 		$107K Sell
2,248
-493
-18% -$24.8K 0.03% 277
2021
Q2 		$136K Buy
2,741
+31
+1% +$1.49K 0.03% 254
2021
Q1 		$120K Buy
+2,710
New +$123K 0.04% 249

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GPS Wealth Strategies Group's GSK Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its GSK (GSK) stake by 64% in Q4 2025, selling an estimated $54.3K and leaving 660 shares worth $32.4K. The position accounts for 0.03% of the portfolio, ranked #261.

GPS Wealth Strategies Group first reported a position in GSK in Q1 2021 and has held it in 19 quarters since. The position peaked at $136K in Q2 2021. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • GPS Wealth Strategies Group held 660 shares of GSK worth $32.4K as of Q4 2025.
  • GPS Wealth Strategies Group sold 1,165 GSK shares in Q4 2025, an estimated $54.3K.
  • GSK made up 0.03% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #261 holding.
  • GPS Wealth Strategies Group first reported a position in GSK in Q1 2021 and has held it in 19 quarters since.
  • GPS Wealth Strategies Group's GSK position peaked at $136K in Q2 2021.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.